As of June 2026 SK Biopharmaceuticals has a market cap of NZ$7.76 Billion. This makes SK Biopharmaceuticals the world's 3348th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.